JPRN-jRCT2080220921未知1 期
A Phase I, Open-label, Multiple-dose, Dose-escalation Study To Assess the Safety and Tolerability of AZD8931 Monotherapy in Japanese Patients With Advanced Solid Malignancies and in Combination With Paclitaxel in Japanese Female Patients With Advanced Breast Cancer
试验速览
- 阶段
- 1 期
- 发起方
- AstraZeneca
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Cancer that is refractory to standard therapies, or for which no standard therapies exist (monotherapy part)
- •-Patients suitable for Paclitaxel chemotherapy, who are not candidates for hormonal and anthracycline therapy (combination part)
- •-Life expectancy more than 12 weeks
排除标准
- •-Inadequate kidney, liver, heart, gastric, lung or eye function
- •-Brain metastases
- •-Hypersensitive to paclitaxel (combination part)
研究者
相似试验
已完成
1 期
A Study Of Phase I multiple dose escalation trial of ZYIL1 Via Oral Route To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Healthy Adult Human SubjectsCTRI/2021/07/034692Cadila Healthcare Ltd18
未知
1 期
A Phase 1, Open-label, Single-arm, Dose-escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI-573, a Fully Human Monoclonal Antibody Directed Against Insulin-like Growth Factors 1 and 2, in Japanese Subjects With Advanced Solid Tumours Refractory to Standard Therapy or for Which No Standard Therapy ExistsJPRN-jRCT2080221544AstraZeneca
进行中（未招募）
1 期
A safety and efficacy study in Children with Metachromatic Leukodystrophy recieving enzyme (HGT-1110) replacement by intrathecal injectioEUCTR2011-002044-28-DEShire Human Genetics Therapies Inc24
进行中（未招募）
1 期
A safety and efficacy study in Children with Metachromatic Leukodystrophy recieving enzyme (HGT-1110) replacement by intrathecal injectioEUCTR2011-002044-28-DKShire Human Genetics Therapies Inc24
已完成
1 期
A study to evaluate the safety of a single dose of increasing amounts of PF0713 given via a vein to healthy adult male volunteersAnaesthesiaAnaesthesiology - AnaestheticsACTRN12608000602325PharmacoFore, Inc.39